The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sivolap Iu.P.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Damulin I.V.

kafedra nervnykh bolezneĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Voskresenskaia O.N.

Kafedra nevrologii FPK PPS GOU VPO Saratovskogo gosudarstvennogo meditsinskogo universiteta im. V.I. Razumovskogo

Traumatic brain injury: neurologic and psychiatric aspects

Authors:

Sivolap Iu.P., Damulin I.V., Voskresenskaia O.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(9): 94‑98

DOI: 10.17116/jnevro20171179194-98

Read: 4389 times

Download PDF (RU)
Contact the author
Table of contents

TRAUMATIC BRAIN INJURY: NEUROLOGIC AND PSYCHIATRIC ASPECTS
TRAUMATIC BRAIN INJURY: NEUROLOGIC AND PSYCHIATRIC ASPECTS

To cite this article:

Sivolap IuP, Damulin IV, Voskresenskaia ON. Traumatic brain injury: neurologic and psychiatric aspects. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(9):94‑98. (In Russ.)
https://doi.org/10.17116/jnevro20171179194-98

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Glial fibrillary acidic protein: is there a rela­tionship with the course of multiple scle­rosis and traumatic brain injury before the onset of multiple scle­rosis?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):80-84
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Como­rbidity of depression and deme­ntia: epidemiological, biological and therapeutic aspe­cts. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):113-121
Acti­vation of endo­genous mechanisms of sano­genesis in cognitive impairment in cere­bral small vessel disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):7-13
Cognitive impairment in bili­nguals with neurological diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):26-29
The rela­tionship between neuropsychological indi­cators and neuroimaging changes acco­rding to MRI morphometry in patients with Alzheimer’s disease and glaucoma. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):142-152
Non-invasive biomarkers for early diagnosis of Alzheimer’s disease in bodily fluids. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):8-16
Nutritional care for patients with neurodegenerative diseases in the outpatient practice of a neurologist. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):76-83
The expe­rience of diagnosing Alzheimer’s disease based on the study of cere­brospinal fluid biomarkers. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):91-97
Nutrition correction in the complex therapy and reha­bilitation of the posttraumatic stress diso­rder. Russian Journal of Preventive Medi­cine. 2025;(2):114-119
Abstract:

Traumatic brain injury is among the leading social-medical problems that causes preventable deaths, health deterioration and disability in young individuals. It is manifested by neurologic and psychiatric disorders, firstly by neurocognitive impairment. Therapeutic interventions in traumatic brain injury include correction of cerebral disorders in the acute phase of trauma, treatment of neurocognitive impairment and symptomatic treatment of mental disorders. The efficacy of treatment of neurocognitive deficits associated with brain injury is still unsatisfactory, which determines the need to find new medicines and therapeutic approaches.

Keywords:

traumatic brain injury
posttraumatic stress disorder
neurocognitive disorders
frontal lobe syndrome
mood disorders
psychosis
dementia
Alzheimer’s disease

Authors:

Sivolap Iu.P.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Damulin I.V.

kafedra nervnykh bolezneĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Voskresenskaia O.N.

Kafedra nevrologii FPK PPS GOU VPO Saratovskogo gosudarstvennogo meditsinskogo universiteta im. V.I. Razumovskogo

Close metadata

References:

  1. Dougall D, Poole N, Agrawal N. Pharmacotherapy for chronic cognitive impairment in traumatic brain injury. Cochrane Database Syst Rev. 2015;12:CD009221. https://doi.org/10.1002/14651858.CD009221.pub2
  2. Black DW, Andreasen NC. Introductory Textbook of Psychiatry. Sixth Edition. Arlington: American Psychiatric Publishing; 2014.
  3. Corbo V, Amick MA, Milberg WP, McGlinchey RE, Salat DH. Early life trauma is associated with altered white matter integrity and affective control. J Psychiatr Res. 2016;79:70-77. https://doi.org/10.1016/j.jpsychires.2016.05.001
  4. Sussman D, Pang EW, Jetly R, Dunkley BT, Taylor MJ. Neuroanatomical features in soldiers with post-traumatic stress disorder. BMC Neurosci. 2016;17:13. https://doi.org/10.1186/s12868-016-0247-x
  5. Shively S, Scher AI, Perl DP, Diaz-Arrastia R. Dementia resulting from traumatic brain injury: what is the pathology? Arch Neurol. 2012;69(10):1245-1251.
  6. Caplan HW, Cox CS, Bedi SS. Do microglia play a role in sex differences in TBI? J Neurosci Res. 2017;95(1-2):509-517. https://doi.org/10.1002/jnr.23854
  7. Semple D, Smyth R. Oxford Handbook of Psychiatry. Third Edition. Oxford: Oxford University Press; 2013.
  8. Lane KS, St Pierre ME, Lauterbach MD, Koliatsos VE. Patient profiles of criminal behavior in the context of traumatic brain injury. J Forensic Sci. 2016. https://doi.org/10.1111/1556-4029.13289
  9. Giuliano S, Talarico S, Bruno L, Nicoletti FB, Ceccotti C, Belfiore A. Growth hormone deficiency and hypopituitarism in adults after complicated mild traumatic brain injury. Endocrine. 2016. https://doi.org/10.1007/s12020-016-1183-3
  10. Crane PK, Gibbons LE, Dams-O’Connor K, Trittschuh E, Leverenz JB, Keene CD, Sonnen J, Montine TJ, Bennett DA, Leurgans S, Schneider JA, Larson EB. Association of traumatic brain injury with late-life neurodegenerative conditions and neuropathologic findings. JAMA Neurol. 2016;73(9):1062-1069. https://doi.org/10.1001/jamaneurol.2016.1948
  11. Edwards G 3rd, Moreno-Gonzalez I, Soto C. Amyloid-beta and tau pathology following repetitive mild traumatic brain injury. Biochem Biophys Res Commun. 2016;S0006-291X(16)31252-31259. https://doi.org/10.1016/j.bbrc.2016.07.123
  12. Washington PM, Villapol S, Burns MP. Polypathology and dementia after brain trauma: does brain injury trigger distinct neurodegenerative diseases, or should they be classified together as traumatic encephalopathy? Exp Neurol. 2016;275(3):381-388. https://doi.org/10.1016/j.expneurol.2015.06.015
  13. Xu ZM, Yuan F, Liu YL, Ding J, Tian HL. Glibenclamide attenuates blood-brain barrier disruption in adult mice following traumatic brain injury. J Neurotrauma. 2016. https://doi.org/10.1089/neu.2016.4491
  14. Khan M, Im YB, Shunmugavel A, Gilg AG, Dhindsa RK, Singh AK, Singh I. Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. J Neuroinflammation. 2009;6:32. https://doi.org/10.1186/1742-2094-6-32
  15. Hadanny A, Efrati S. Treatment of persistent post-concussion syndrome due to mild traumatic brain injury: current status and future directions. Expert Rev Neurother. 2016;16(8):875-887. https://doi.org/10.1080/14737175.2016.1205487
  16. Gultekin R, Huang S, Clavisi O, Pattuwage L, König TC, Gruen R. Pharmacological interventions in traumatic brain injury: can we rely on systematic reviews for evidence? Injury. 2016;47(3):516-524. https://doi.org/10.1016/j.injury.2015.10.011
  17. Gruenbaum SE, Zlotnik A, Gruenbaum BF, Hersey D, Bilotta F. Pharmacologic neuroprotection for functional outcomes after traumatic brain injury: a systematic review of the clinical literature. CNS Drugs. 2016;30(9):791-806. https://doi.org/10.1007/s40263-016-0355-2
  18. Maksimowski MB, Tampi RR. Efficacy of stimulants for psychiatric symptoms in individuals with traumatic brain injury. Ann Clin Psychiatry. 2016;28(3):156-166.
  19. McDonald BC, Flashman LA, Arciniegas DB, Ferguson RJ, Xing L, Harezlak J, Sprehn GC, Hammond FM, Maerlender AC, Kruck CL, Gillock KL, Frey K, Wall RN, Saykin AJ, McAllister TW. Methylphenidate and memory and attention adaptation training for persistent cognitive symptoms after traumatic bain injury: a randomized, placebo-controlled trial. Neuropsychopharmacology. 2016. https://doi.org/10.1038/npp.2016.261
  20. Rossom RC, Rector TS, Lederle FA, Dysken MW. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia? J Am Geriatr Soc. 2010;58(6):1027-1034. https://doi.org/10.1111/j.1532-5415.2010.02873.x
  21. Weintraub D, Chiang C, Kim HM, Wilkinson J, Marras C, Stanislawski B, Mamikonyan E, Kales HC. Association of antipsychotic use with mortality risk in patients with Parkinson disease. JAMA Neurol. 2016;73(5):535-541. https://doi.org/10.1001/jamaneurol.2016.0031
  22. Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, Kales HC. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry. 2015;72(5):438-445. https://doi.org/10.1001/jamapsychiatry.2014.3018
  23. Fox LC, Davies DR, Scholl JL, Watt MJ, Forster GL. Differential effects of glucocorticoid and mineralocorticoid antagonism on anxiety behavior in mild traumatic brain injury. Behav Brain Res. 2016;312:362-365. https://doi.org/10.1016/j.bbr.2016.06.048
  24. Soo C, Tate R. Psychological treatment for anxiety in people with traumatic brain injury. Cochrane Database Syst Rev. 2007;3:CD005239. https://doi.org/10.1002/14651858.CD005239.pub2
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.